American International Group’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-10,652
| Closed | -$1.9M | – | 1441 |
|
2024
Q1 | $1.9M | Sell |
10,652
-92
| -0.9% | -$16.4K | 0.01% | 1025 |
|
2023
Q4 | $1.33M | Sell |
10,744
-43
| -0.4% | -$5.34K | 0.01% | 1157 |
|
2023
Q3 | $1.25M | Buy |
10,787
+383
| +4% | +$44.4K | 0.01% | 1128 |
|
2023
Q2 | $1.22M | Buy |
10,404
+108
| +1% | +$12.7K | 0.01% | 1146 |
|
2023
Q1 | $824K | Buy |
10,296
+204
| +2% | +$16.3K | 0.01% | 1317 |
|
2022
Q4 | $799K | Sell |
10,092
-37
| -0.4% | -$2.93K | 0.01% | 1328 |
|
2022
Q3 | $706K | Buy |
10,129
+325
| +3% | +$22.7K | 0.01% | 1374 |
|
2022
Q2 | $644K | Sell |
9,804
-184
| -2% | -$12.1K | ﹤0.01% | 1451 |
|
2022
Q1 | $665K | Buy |
9,988
+457
| +5% | +$30.4K | ﹤0.01% | 1569 |
|
2021
Q4 | $667K | Sell |
9,531
-284
| -3% | -$19.9K | ﹤0.01% | 1637 |
|
2021
Q3 | $512K | Sell |
9,815
-234
| -2% | -$12.2K | ﹤0.01% | 1842 |
|
2021
Q2 | $683 | Buy |
10,049
+1,265
| +14% | +$86 | ﹤0.01% | 1743 |
|
2021
Q1 | $677 | Buy |
8,784
+925
| +12% | +$71 | ﹤0.01% | 1670 |
|
2020
Q4 | $472 | Sell |
7,859
-226
| -3% | -$14 | ﹤0.01% | 1785 |
|
2020
Q3 | $348K | Buy |
8,085
+775
| +11% | +$33.4K | ﹤0.01% | 1788 |
|
2020
Q2 | $303K | Buy |
7,310
+1,097
| +18% | +$45.5K | ﹤0.01% | 1871 |
|
2020
Q1 | $269K | Sell |
6,213
-360
| -5% | -$15.6K | ﹤0.01% | 1742 |
|
2019
Q4 | $364K | Sell |
6,573
-55
| -0.8% | -$3.05K | ﹤0.01% | 1873 |
|
2019
Q3 | $230K | Buy |
6,628
+1,056
| +19% | +$36.6K | ﹤0.01% | 2083 |
|
2019
Q2 | $224K | Buy |
+5,572
| New | +$224K | ﹤0.01% | 2152 |
|